MygenoMD is a Delaware-based company that offers a Software-as-a-Service telehealth platform. Their platform combines genetic data and AI to deliver personalized healthcare to patients through remote monitoring and automation technologies. By collecting genomic data through an at-home kit, MygenoMD aims to make genetic information easily accessible and affordable for everyone, offering insights into the likelihood of developing diseases like cancer and identifying personalized treatment options. With MygenoMD, individuals with chronic diseases can receive personalized treatments without the need to travel or spend excessive amounts of money.